ALLO-329 Allogeneic CART Treatment for Autoimmune Disease

Why do some patients with IBD keep failing advanced therapies—even when everything “looks right”? At #CrohnsColitisCongress2026 , experts challenged the idea of true “treatment-refractory” disease and pointed to a much more layered explanation. 👉 The answer might not be what we’ve been assuming. Read more: https://lnkd.in/e8AQrQMK #GI #IBD

Why do some patients with IBD keep failing advanced therapies—even when everything “looks right”? At #CrohnsColitisCongress2026 , experts challenged the idea of true “treatment-refractory” disease and pointed to a much more layered explanation. 👉 The answer might not be what we’ve been assuming. Read more: https://lnkd.in/e8AQrQMK #GI #IBD

Why do some patients with IBD keep failing advanced therapies—even when everything “looks right”? At #CrohnsColitisCongress2026 , experts challenged the idea of true “treatment-refractory” disease and pointed to a much more layered explanation. 👉 The answer might not be what we’ve been assuming. Read more: https://lnkd.in/e8AQrQMK #GI #IBD

Why do some patients with IBD keep failing advanced therapies—even when everything “looks right”? At #CrohnsColitisCongress2026 , experts challenged the idea of true “treatment-refractory” disease and pointed to a much more layered explanation. 👉 The answer might not be what we’ve been assuming. Read more: https://lnkd.in/e8AQrQMK #GI #IBD

#FabryDisease is often diagnosed late because its symptoms vary widely and current #DiagnosticTools can miss the condition, limiting the benefits of treatment.  This review highlights how #Multiomics is transforming our understanding of Fabry disease, uncovering #biomarkers and therapeutic targets that could enable earlier diagnosis and more personalized care. @southeast-university #OpenAccess: https://lnkd.in/dDgYESMX  

enVVeno Medical is advancing innovative venous disease technologies with the goal of improving outcomes for patients suffering from chronic venous insufficiency. #NVNO #VenousDisease #DeepVenousInsufficiency #CVI #CVD

enVVeno Medical is advancing innovative venous disease technologies with the goal of improving outcomes for patients suffering from chronic venous insufficiency. #NVNO #VenousDisease #DeepVenousInsufficiency #CVI #CVD

Dose individualization has long been a limiting factor in long-term TKI therapy for GIST, particularly for patients facing GI barriers to consistent oral intake. Jonathan C. Trent, MD, PhD, discusses how Imkeldi allows for more precise titration across a wider dose range, something oral tablets and capsules like sunitinib simply can't offer. He also outlines how proactive adverse effect management and patient-centered dosing conversations remain essential to durable disease control. Read the full analysis: https://hubs.ly/Q04nV6Vc0 #GIST #GastrointestinalStromalTumor #Imatinib #OncologyPharmacy #TKITherapy

Schirmer Test (Tear Test) – Quick Revision 👁️ The Schirmer test is a simple yet essential clinical test used to assess tear production and aid in the diagnosis of Dry Eye Disease (Keratoconjunctivitis Sicca).

“The most important part is for people who have not yet come to your clinic.” At the 2026 Western Atrial Fibrillation Symposium, Han Feng, PhD, discussed how smartwatch-based monitoring could help patients with conditions such as diabetes or coronary artery disease recognize a potential AFib risk and seek evaluation sooner. https://hubs.ly/Q04n6NfC0 #WAFIB2026